Latest News

We wouldn't blame Montage Gold Corp. ( TSE:MAU ) shareholders if they were a little worried about the fact that Richard...

Renasant stock snapshot after recent performance shift Renasant (RNST) has drawn fresh attention after a recent shift in its share performance, with the stock showing mixed short term moves but double digit gains over the past month and past 3 months. See our latest analysis for Renasant. At the current share price of $39.40, Renasant has seen a 1 day share price return of 0.86% decline, while its recent 30 day share price return of 10.49% and 1 year total shareholder return of 45.91% reflect...

Affiliated Managers Group (AMG) highlighted 2025 as one of its strongest years, pointing to over US$1b committed to alternative strategies, new U.S. wealth market collaborations, sizable share repurchases, and capital structure refinancing as key developments. See our latest analysis for Affiliated Managers Group. The recent commitments to alternative strategies and U.S. wealth partnerships come as the share price trades at US$285.36, with a 7.5% 7 day share price return but a 90 day share...

Zions Bancorporation National Association (ZION) has drawn fresh attention after its recent share price move, with the stock showing mixed short term performance but significantly different returns over the past year. See our latest analysis for Zions Bancorporation National Association. The latest move to US$61.05 comes after a 15% 30 day share price return and a 50% 1 year total shareholder return. This suggests momentum has been building despite some recent day to day volatility. If Zions'...

ZEISS parent Carl Zeiss Meditec (XTRA:AFX) has drawn fresh attention after unveiling the ZEISS Crossbeam 750 FIB SEM, a high precision system aimed at semiconductor, nanofabrication, and materials science workflows. See our latest analysis for Carl Zeiss Meditec. While the ZEISS Crossbeam 750 launch has coincided with a 9.82% 1 month share price return and a 4.43% 7 day share price return, the 1 year total shareholder return of 50.70% and 5 year total shareholder return of 81.22% suggest that...

Earlier this week, BTIG Research initiated analyst coverage on Evergy with a Buy rating, citing substantial earnings growth potential and a supportive regulatory backdrop in its Midwestern service territories. The coverage highlights how Evergy’s earnings profile could eventually warrant a premium valuation within the utility sector if its growth plans materialize as expected. We’ll now examine how BTIG’s emphasis on Evergy’s earnings growth prospects interacts with the existing investment...

In recent days, multiple research firms including Keefe, Bruyette & Woods, Barclays and Wells Fargo have updated their views on Corebridge Financial, largely reaffirming positive ratings such as “Outperform” and “Overweight” while revising their assessments of the company’s outlook. This cluster of analyst actions highlights sustained institutional interest in Corebridge’s business model and market position, even as opinions on its prospects are being recalibrated. Next, we’ll examine how...

We wouldn't blame Box, Inc. ( NYSE:BOX ) shareholders if they were a little worried about the fact that Eliahu...

Sales update and leadership change draw attention to Buckle (BKE) Buckle (BKE) has drawn fresh investor attention after reporting higher comparable store and total net sales for recent 5 week and 9 week periods, alongside appointing longtime executive Scott A. Werth as Senior Vice President of Stores. See our latest analysis for Buckle. Buckle’s recent sales update and leadership change arrived after a mixed share price pattern, with a 9.4% 7 day share price return and a 71.3% 1 year total...

Pulse Biosciences recently expanded its leadership team, appointing Liane Teplitsky as Chief Operating Officer and increasing Dr. David Kenigsberg’s role as full-time Chief Medical Officer to accelerate development and future commercialization of the nPulse Cardiac Catheter Ablation System for atrial fibrillation. These leadership moves follow the first patient enrollments in the pivotal NANOPULSE-AF study, underscoring the company’s focus on turning its nanosecond pulsed field ablation...

Navios Maritime Partners recently reported quarterly results that exceeded analyst expectations for both earnings per share and revenue, highlighting strong operational execution in its global shipping business. This outperformance has drawn fresh attention to how the partnership’s existing fleet strategy and cost discipline may be supporting stronger-than-expected profitability. We’ll now examine how this earnings and revenue beat could influence Navios Maritime Partners’ investment...

Why the restatement matters for Weis Markets (WMK) Weis Markets (WMK) has drawn fresh scrutiny after disclosing plans to restate multiple prior year audited financial statements due to overstated inventory and delaying its 2025 annual report filing. Law firm Bronstein, Gewirtz & Grossman, LLC is now investigating potential claims on behalf of shareholders, a development that followed a sharp stock price drop and has pushed accounting quality and disclosure risk to the forefront for...

Quarterly earnings put TowneBank (TOWN) in focus TowneBank (TOWN) is back on investor radars after mixed quarterly results, with revenue up 23.6% year on year and tangible book value per share ahead of analyst expectations, while net interest income fell short. See our latest analysis for TowneBank. At a share price of US$35.85, TowneBank has recently seen momentum edge higher, with a 7 day share price return of 5.75% and a 1 month share price return of 8.67%. Its 1 year total shareholder...

Cellebrite DI Ltd. recently released its Spring 2026 update, expanding lawful access across a wider range of iOS and Android devices, adding Safeguard Mode for time-sensitive data capture, introducing field-ready drone forensics, and bringing Corellium’s virtualized Arm-based testing environment into public preview on Google Cloud. By combining broader device coverage, cloud-based virtual testing and new drone data extraction, the release pushes Cellebrite further into complex, data-rich...

On 1 April 2026, IDEXX Laboratories launched the IDEXX Cancer Dx Panel in the UK, offering a blood-based test for early detection of lymphoma in at-risk dogs via its reference laboratories, with results available in 3–5 business days and veterinarian pricing starting from £22.50. The UK introduction builds on adoption by nearly 6,000 practices in North America and underscores IDEXX’s push to embed cancer screening into routine preventative care, supported by research showing strong pet owner...

Baytex Energy (TSX:BTE) is back on investor radar after renewed institutional buying coincided with oil trading above $100 per barrel, tighter earnings projections, and upbeat insider sentiment around its Canadian heavy oil and Duvernay assets. See our latest analysis for Baytex Energy. At a share price of CA$5.72, Baytex has posted a 21.7% 90 day share price return and a very large 1 year total shareholder return of 159.4%. This suggests momentum has been building as oil prices climbed and...

Considering whether Transocean at US$6.52 still offers value after a strong run, or whether most of the upside is already reflected in the price. The stock has seen mixed short term moves, with a 1.1% decline over the last 7 days and a 2.5% gain over 30 days, while the year to date return sits at 53.8% and the 1 year return at 188.5%. Recent coverage has focused on Transocean as an offshore drilling contractor and how sentiment around the sector, contract activity, and balance sheet...

DTE Energy (DTE) is back in focus after securing a long-term clean energy supply agreement with Google for a planned 1 gigawatt data center in southeast Michigan, supported by battery storage and solar projects. See our latest analysis for DTE Energy. DTE Energy’s share price has been firming, with a 14.9% 90 day share price return and 14.8% year to date share price return. The 1 year total shareholder return of 19.2% reflects improving sentiment as investors weigh the Google agreement,...

Primerica recently released its latest Financial Security Monitor survey, revealing that about 65% of middle-income Americans have delayed major expenses such as home repairs, medical procedures, and vehicle purchases over the past year because their income is lagging behind the rising cost of living. CEO Glenn J. Williams emphasized that even amid this strain, families can improve financial confidence through small steps like scrutinizing everyday expenses and using tax refunds more...

Dividend decision and what it means for Holmen (OM:HOLM B) shareholders Holmen (OM:HOLM B) confirmed at its 30 March 2026 AGM a dividend of SEK 9.50 per share, with a record date of 1 April and expected payment on 8 April. This gives investors clear timing on cash returns. The AGM also re elected PricewaterhouseCoopers AB as auditor. This is a routine but relevant detail for those who care about oversight of Holmen’s SEK 22,805m in revenue and SEK 2,879m in net income, both reported in...

Over the past few days, several major Wall Street firms, including Wells Fargo and UBS, have reaffirmed neutral ratings on Molson Coors Beverage while adopting a more cautious stance on its outlook. This shift reflects a broader cooling of analyst confidence in the company’s near-term prospects, despite its position as a key North American beer producer. Next, we’ll examine how this broader analyst caution toward Molson Coors’ near-term prospects could reshape its longer-term investment...

In early April 2026, Banco Santander, S.A. completed several US dollar bond issues, including US$400 million of floating‑rate notes due 2029 and US$3.25 billion of fixed‑rate senior and non‑preferred notes maturing between 2029 and 2036, all issued at around par and featuring callable, unsecured, unsubordinated structures. Over roughly the same period, the bank disclosed that it has invested about €2.7 billion in an ongoing share buyback programme, retiring around 16.8% of its 2021 share...

In recent days, Atour Lifestyle Holdings reported a fourth-quarter earnings beat that pointed to stronger-than-expected business momentum, coinciding with easing geopolitical tensions after a U.S.-Iran ceasefire that supported travel and consumer names. An interesting aspect is how this combination of robust operating performance and lower oil-related macro risk has drawn in both fundamental and technically focused investors eyeing the company’s operating profile. We’ll now examine how this...

Why Perimeter Solutions (PRM) Is Back on Investor Radars Perimeter Solutions (PRM) has drawn fresh attention after reporting 2025 sales growth of 16% and spotlighting momentum in its specialty products segment, alongside a US$685 million purchase of Medical Manufacturing Technologies. See our latest analysis for Perimeter Solutions. The share price has moved higher over the past month, with a 1 month share price return of 11.95%. However, the year to date share price return of 7.38% and 90...